EDAP TMS—which transitioned its corporate identity to FocalTherics—hosted its major annual Analyst and Investor Day on Monday, June 1, 2026. The comprehensive event featured presentations led by the executive leadership team alongside prominent urologic surgeons specializing in focal therapy and Focal One HIFU technology. Discussions during the broadcast covered the company's strategic growth plans, long-term financial targets, expanded therapeutic indications, and its ongoing leadership in robotic energy-based therapies following its official ticker symbol transition to FOCL on the Nasdaq exchange.